+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biobanking Market by Sample Type, Storage Type, Service, End User, Application - Global Forecast to 2030- Product Image
Biobanking Market by Sample Type, Storage Type, Service, End User, Application - Global Forecast to 2030- Product Image
Sale

Biobanking Market by Sample Type, Storage Type, Service, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082571
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biobanking Market grew from USD 78.21 billion in 2024 to USD 87.53 billion in 2025. It is expected to continue growing at a CAGR of 11.82%, reaching USD 152.93 billion by 2030.

Pioneering the Future of Biobanking with Integrated Excellence

Biobanking has emerged as a critical cornerstone in the life sciences ecosystem, underpinning breakthroughs in diagnostics, therapeutics, and personalized medicine. As repositories of biological specimens and associated data, modern biobanks facilitate collaborations across academia, industry, and clinical research, enabling unprecedented insights into human health and disease. This executive summary distills the most pressing trends, strategic shifts, and nuanced market dynamics shaping the global biobanking sector. It highlights transformative technological advancements, evolving regulatory frameworks, and the cumulative effects of policy changes in key markets. By weaving together segmentation analyses, regional performance, and competitive landscapes, the following sections offer a holistic perspective that empowers decision-makers to navigate complexity with confidence. Whether you are an executive steering portfolio investments or a research leader seeking to optimize specimen workflows, the insights herein will illuminate the pathways to sustainable growth and innovation in biobanking.

Catalysts of Change Redefining Biobanking for Advanced Research

The biobanking landscape is being reshaped by several converging forces that collectively elevate operational efficiency and scientific impact. Foremost is the rapid integration of automation and artificial intelligence in sample management, which streamlines high-throughput processing while minimizing human error. Advances in digital tracking systems and blockchain-enabled provenance verification are bolstering data integrity and bolstering stakeholder trust. Meanwhile, regulatory bodies worldwide are converging around harmonized standards for consenting, privacy protection, and cross-border sample transfers, reducing friction for multinational collaborations. Sustainability has also ascended as a transformative theme, spurring the adoption of energy-efficient storage solutions and green cryogenics. Additionally, the COVID-19 pandemic has accelerated remote engagement models, amplifying the demand for decentralized collection networks and virtual data management platforms. Taken together, these shifts are redefining best practices, driving economies of scale, and empowering biobanks to deliver more robust, reproducible research outcomes for a diverse set of end users.

Navigating the 2025 US Tariff Wave Impacting Biobanking Supply Chains

In 2025, newly imposed tariffs in the United States are exerting a cumulative impact across the biobanking value chain. Import duties on specialized reagents and consumables have driven up procurement costs, prompting organizations to renegotiate supplier agreements and explore regional sourcing alternatives. Capital equipment for cryogenic and ultra low temperature storage is also subject to increased duties, extending project timelines and elevating budgetary risk. Freight and packaging expenses have risen in tandem, as logistics providers adjust to the altered cost base. Faced with these headwinds, biobank operators are strengthening partnerships with domestic manufacturers and investing in modular infrastructure that can be repurposed across multiple projects. They are also optimizing inventory strategies through just-in-time delivery models, reducing on-site holding costs while maintaining specimen integrity. By proactively addressing tariff-related challenges, industry leaders are safeguarding research continuity and preserving margins in an increasingly protectionist environment.

Deep-Dive Segmentation Reveals Nuanced Market Dynamics

A granular segmentation analysis reveals the multifaceted nature of demand within the biobanking market. When examining sample type, blood in its various forms-whether plasma prepared for high-throughput assays, serum for biomarker discovery, or whole blood for hematological analysis-continues to dominate, while specialized cell repositories encompassing established cell lines and patient-derived primary cells support an expanding array of research programs. DNA and RNA collections have surged as genomic and transcriptomic studies proliferate, and tissue banking, whether through formalin-fixed paraffin-embedded blocks or fresh frozen specimens, underpins histological and molecular investigations. Storage modalities reflect analogous diversity: ambient storage accommodates room-temperature stabilization solutions, cold storage employs refrigerated units, cryogenic methods leverage liquid nitrogen vapor phases for ultra-stability, and ultra low temperature systems serve critical long-term preservation needs. Service offerings have evolved in parallel, spanning initial specimen collection, sophisticated data management platforms, distribution channels ranging from cold chain logistics to standard shipping, and processing workflows including cell separation, nucleic acid extraction and tissue sectioning alongside both short-term and extended storage solutions. End users are equally varied-from academic research institutions and clinical trial centers to contract research organizations and biotechnology firms-each demanding tailored capabilities that align with their scientific and compliance requirements. Across applications, agriculture genetics programs, in vitro diagnostics development, drug discovery pipelines and the burgeoning field of personalized medicine collectively drive robust market growth by applying biobanked materials to real-world challenges.

Regional Variations Driving Global Biobanking Growth Trajectories

Geographical variation underscores the global scope and localized drivers of the biobanking sector. In the Americas, a mature market benefits from substantial public and private research funding, extensive clinical trial activity and strong infrastructure for specimen procurement and distribution. Leading academic consortia and expansive healthcare networks continue to fuel demand for advanced storage and data management solutions. Across Europe, the Middle East & Africa region, harmonized regulatory guidelines such as the GDPR provide a framework for cross-border sample sharing, while investments in pan-European biobank infrastructures and emerging programs in the Gulf Cooperation Council countries broaden access to diverse specimen collections. Meanwhile, the Asia-Pacific region exhibits some of the fastest growth rates, propelled by significant government initiatives in genomics and precision health across China, Japan and South Korea, alongside burgeoning biotech hubs in India and Southeast Asia. Collectively, these regional dynamics illustrate how funding landscapes, regulatory environments and local partnerships shape adoption curves and competitive positioning worldwide.

Competitive Landscape Shaped by Strategic Innovation and Collaboration

The competitive landscape is characterized by a dynamic interplay of full-service biobanking providers, specialized equipment manufacturers and digital solution vendors. Industry leaders have distinguished themselves through vertical integration strategies that couple specimen storage with end-to-end informatics platforms, enabling seamless data capture and analytics. Strategic alliances and selective acquisitions have expanded portfolios to include emerging technologies such as lab-on-a-chip devices and automated aliquoting robots. Key players are also investing heavily in sustainability controls, adopting green nitrogen generation and energy-efficient freezers to meet corporate social responsibility targets. Meanwhile, innovative pure-play biobank operators are carving out niches by focusing on rare disease repositories and decentralized collection networks. Across the board, successful organizations leverage rigorous quality management systems, ISO certifications and user-centric digital dashboards to differentiate their service offerings and secure long-term partnerships with pharmaceutical, academic and government stakeholders.

Strategic Imperatives to Propel Biobanking Industry Leadership

To maintain a leadership position, industry stakeholders must adopt a multi-pronged strategic approach. Investing in fully automated sample handling and high-capacity storage infrastructure will reduce operational bottlenecks and lower per-specimen costs. Diversification of reagent and equipment suppliers, combined with flexible contract structures, will mitigate the impact of policy shifts and market disruptions. Prioritizing digital transformation through cloud-native data management platforms, AI-driven analytics and real-time dashboards will enhance decision-making and foster transparency. Strategic partnerships with academic institutions, clinical research sites and emerging biotech clusters can accelerate biobank expansion and broaden access to high-value specimens. Finally, embedding sustainability by adopting energy-efficient freezers, reducing single-use plastics and implementing circular supply chain initiatives will not only meet regulatory expectations but also resonate with environmentally conscious stakeholders.

Robust Methodological Framework Underpinning Market Insights

This report is founded on a rigorous research methodology combining primary and secondary data collection. In the secondary phase, over 150 industry publications, regulatory filings, corporate presentations and patent databases were reviewed to map historical developments and emerging technology trends. Primary research comprised structured interviews with more than 30 senior executives, laboratory managers and procurement specialists across key geographies, supplemented by insights from independent biobanking consultants. Quantitative data were triangulated to ensure consistency and validated through cross-referencing of multiple sources. Competitive benchmarking was conducted using publicly available financial reports and proprietary deal databases. The synthesis of qualitative and quantitative findings was subjected to a multi-stage review process involving subject-matter experts to guarantee accuracy, relevance and actionable insight. This robust framework underpins the credibility of the market intelligence and strategic recommendations presented.

Synthesis of Insights Guiding Future Biobanking Endeavors

The global biobanking sector stands at an inflection point where technological sophistication, regulatory convergence and evolving research needs converge to create unprecedented opportunities. As automated workflows and digital platforms become ubiquitous, biobanks will unlock new efficiencies and scientific breakthroughs. At the same time, dynamic policy environments and tariff pressures necessitate agile supply chain strategies and proactive risk management. Our segmentation and regional analyses reveal that success will hinge on the ability to tailor services to specific research modalities, end-user requirements and geographic nuances. Leading organizations will be those that integrate advanced analytics, sustainability imperatives and strategic alliances into cohesive growth plans. This body of work synthesizes core insights to guide executives and practitioners in making data-driven decisions that secure competitive advantage and propel the next wave of innovation in biobanking.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Sample Type
    • Blood
      • Plasma
      • Serum
      • Whole Blood
    • Cells
      • Cell Lines
      • Primary Cells
    • DNA/RNA
    • Tissue
      • FFPE
      • Fresh Frozen
  • Storage Type
    • Ambient Storage
    • Cold Storage
    • Cryogenic Storage
      • Liquid Nitrogen
      • Vapor Phase
    • Ultra Low Temperature Storage
  • Service
    • Collection
    • Data Management
    • Distribution
      • Cold Chain Distribution
      • Standard Distribution
    • Processing
      • Cell Separation
      • Nucleic Acid Extraction
      • Tissue Sectioning
    • Storage
      • Long-Term Storage
      • Short-Term Storage
  • End User
    • Academic Research
    • Clinical Research
    • Contract Research Organization
    • Pharmaceutical Biotechnology
  • Application
    • Agriculture
    • Diagnostics
    • Drug Discovery
    • Personalized Medicine
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Azenta Life Sciences, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • BioLife Solutions, Inc.
  • Qiagen N.V.
  • Tecan Group AG
  • PerkinElmer, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biobanking Market, by Sample Type
8.1. Introduction
8.2. Blood
8.2.1. Plasma
8.2.2. Serum
8.2.3. Whole Blood
8.3. Cells
8.3.1. Cell Lines
8.3.2. Primary Cells
8.4. DNA/RNA
8.5. Tissue
8.5.1. FFPE
8.5.2. Fresh Frozen
9. Biobanking Market, by Storage Type
9.1. Introduction
9.2. Ambient Storage
9.3. Cold Storage
9.4. Cryogenic Storage
9.4.1. Liquid Nitrogen
9.4.2. Vapor Phase
9.5. Ultra Low Temperature Storage
10. Biobanking Market, by Service
10.1. Introduction
10.2. Collection
10.3. Data Management
10.4. Distribution
10.4.1. Cold Chain Distribution
10.4.2. Standard Distribution
10.5. Processing
10.5.1. Cell Separation
10.5.2. Nucleic Acid Extraction
10.5.3. Tissue Sectioning
10.6. Storage
10.6.1. Long-Term Storage
10.6.2. Short-Term Storage
11. Biobanking Market, by End User
11.1. Introduction
11.2. Academic Research
11.3. Clinical Research
11.4. Contract Research Organization
11.5. Pharmaceutical Biotechnology
12. Biobanking Market, by Application
12.1. Introduction
12.2. Agriculture
12.3. Diagnostics
12.4. Drug Discovery
12.5. Personalized Medicine
13. Americas Biobanking Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biobanking Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biobanking Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Danaher Corporation
16.3.4. Azenta Life Sciences, Inc.
16.3.5. Laboratory Corporation of America Holdings
16.3.6. Eurofins Scientific SE
16.3.7. BioLife Solutions, Inc.
16.3.8. Qiagen N.V.
16.3.9. Tecan Group AG
16.3.10. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOBANKING MARKET MULTI-CURRENCY
FIGURE 2. BIOBANKING MARKET MULTI-LANGUAGE
FIGURE 3. BIOBANKING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOBANKING MARKET SIZE, BY SERVICE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOBANKING MARKET SIZE, BY SERVICE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOBANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOBANKING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOBANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOBANKING MARKET SIZE, BY CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOBANKING MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOBANKING MARKET SIZE, BY DNA/RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOBANKING MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOBANKING MARKET SIZE, BY FFPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOBANKING MARKET SIZE, BY FRESH FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOBANKING MARKET SIZE, BY AMBIENT STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOBANKING MARKET SIZE, BY COLD STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOBANKING MARKET SIZE, BY LIQUID NITROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOBANKING MARKET SIZE, BY VAPOR PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOBANKING MARKET SIZE, BY ULTRA LOW TEMPERATURE STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOBANKING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOBANKING MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOBANKING MARKET SIZE, BY DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOBANKING MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOBANKING MARKET SIZE, BY STANDARD DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOBANKING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOBANKING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOBANKING MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOBANKING MARKET SIZE, BY TISSUE SECTIONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOBANKING MARKET SIZE, BY LONG-TERM STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOBANKING MARKET SIZE, BY SHORT-TERM STORAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOBANKING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOBANKING MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOBANKING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOBANKING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOBANKING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. CANADA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 90. CANADA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 91. CANADA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. GERMANY BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 163. GERMANY BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 193. ITALY BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 194. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 196. ITALY BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 197. ITALY BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 198. ITALY BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 199. ITALY BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 200. ITALY BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 212. SPAIN BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 257. DENMARK BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 258. DENMARK BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 259. DENMARK BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 260. DENMARK BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. QATAR BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 276. QATAR BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 277. QATAR BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 278. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 279. QATAR BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 280. QATAR BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 281. QATAR BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 282. QATAR BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 283. QATAR BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 284. QATAR BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 289. FINLAND BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 290. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 292. FINLAND BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 293. FINLAND BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 294. FINLAND BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 295. FINLAND BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 296. FINLAND BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SWEDEN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 320. NIGERIA BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 324. EGYPT BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 325. EGYPT BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 326. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 327. EGYPT BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 328. EGYPT BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 329. EGYPT BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 330. EGYPT BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 331. EGYPT BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 332. EGYPT BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. TURKEY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 335. TURKEY BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 336. TURKEY BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 337. TURKEY BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 338. TURKEY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 339. TURKEY BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 340. TURKEY BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 341. TURKEY BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 342. TURKEY BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 343. TURKEY BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 344. TURKEY BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. TURKEY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 350. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 352. ISRAEL BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 353. ISRAEL BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 354. ISRAEL BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 355. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 356. ISRAEL BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 357. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 358. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 359. NORWAY BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 360. NORWAY BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 361. NORWAY BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 362. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 363. NORWAY BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 364. NORWAY BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 365. NORWAY BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 366. NORWAY BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 367. NORWAY BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 368. NORWAY BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 369. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 370. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 371. POLAND BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 372. POLAND BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 373. POLAND BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 374. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 375. POLAND BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 376. POLAND BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 377. POLAND BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 378. POLAND BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 379. POLAND BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 380. POLAND BIOBANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 381. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 382. SWITZERLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 383. SWITZERLAND BIOBANKING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 384. SWITZERLAND BIOBANKING MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
TABLE 385. SWITZERLAND BIOBANKING MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 386. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
TABLE 387. SWITZERLAND BIOBANKING MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2030 (USD MILLION)
TABLE 388. SWITZERLAND BIOBANKING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 389. SWITZERLAND BIOBANKING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 390. SWITZERLAND BIOBANKING MARKET SIZE, BY PROCESSING, 2018-2030 (USD MILLION)
TABLE 391. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE, 2018-2030 (USD MILLION)
TABLE 392. SWITZERLAND BIOBANKING

Companies Mentioned

The companies profiled in this Biobanking market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Azenta Life Sciences, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • BioLife Solutions, Inc.
  • Qiagen N.V.
  • Tecan Group AG
  • PerkinElmer, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 87.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 152.93 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biobanking Market Overview, 2024-2029 - Product Image

Biobanking Market Overview, 2024-2029

  • Report
  • 128 Pages
  • Global
From
Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032 - Product Image

Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Biobanking Market Outlook, 2029 - Product Image

Biobanking Market Outlook, 2029

  • Report
  • 257 Pages
  • Global
From
Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Biobanking Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Biobanking Equipment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Biobanking Equipment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.